Detalhe da pesquisa
1.
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study.
Lancet HIV
; 11(4): e211-e221, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538160
2.
Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.
J Infect Dis
; 202(2): 291-301, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20533872
3.
Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children.
J Allergy Clin Immunol
; 119(3): 747-50, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17336619
4.
Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140).
J Allergy Clin Immunol
; 118(2): 518-21, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16890780